Immune checkpoint inhibitors in cancer therapy

Y Shiravand, F Khodadadi, SMA Kashani… - Current …, 2022‏ - mdpi.com
The discovery of immune checkpoint proteins such as PD-1/PDL-1 and CTLA-4 represents a
significant breakthrough in the field of cancer immunotherapy. Therefore, humanized …

CRISPR in cancer biology and therapy

A Katti, BJ Diaz, CM Caragine, NE Sanjana… - Nature Reviews …, 2022‏ - nature.com
Over the past decade, CRISPR has become as much a verb as it is an acronym,
transforming biomedical research and providing entirely new approaches for dissecting all …

Tumor immunotherapies by immune checkpoint inhibitors (ICIs); the pros and cons

A Naimi, RN Mohammed, A Raji, S Chupradit… - Cell communication and …, 2022‏ - Springer
The main breakthrough in tumor immunotherapy was the discovery of immune checkpoint
(IC) proteins, which act as a potent suppressor of the immune system by a myriad of …

Characterization and visualization of tandem repeats at genome scale

E Dolzhenko, A English, H Dashnow… - Nature …, 2024‏ - nature.com
Tandem repeat (TR) variation is associated with gene expression changes and numerous
rare monogenic diseases. Although long-read sequencing provides accurate full-length …

Hot and cold tumors: Immunological features and the therapeutic strategies

L Wang, H Geng, Y Liu, L Liu, Y Chen, F Wu, Z Liu… - MedComm, 2023‏ - Wiley Online Library
Abstract The “hotness” or “coldness” of the tumors are determined by the information of the
cancer cells themselves, tumor immune characteristics, tumor microenvironment, and …

mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges

Z Zou, T Tao, H Li, X Zhu - Cell & bioscience, 2020‏ - Springer
Mammalian target of rapamycin (mTOR) regulates cell proliferation, autophagy, and
apoptosis by participating in multiple signaling pathways in the body. Studies have shown …

Artificial intelligence in oncology: current landscape, challenges, and future directions

W Lotter, MJ Hassett, N Schultz, KL Kehl… - Cancer …, 2024‏ - aacrjournals.org
Artificial intelligence (AI) in oncology is advancing beyond algorithm development to
integration into clinical practice. This review describes the current state of the field, with a …

TMB or not TMB as a biomarker: That is the question

A Addeo, A Friedlaender, GL Banna… - Critical reviews in oncology …, 2021‏ - Elsevier
Immune checkpoint inhibitors (ICIs) have revolutionized the landscape of therapeutic
options for many cancers. These treatments have demonstrated improved efficacy and often …

Advances in artificial intelligence to predict cancer immunotherapy efficacy

J **e, X Luo, X Deng, Y Tang, W Tian… - Frontiers in …, 2023‏ - frontiersin.org
Tumor immunotherapy, particularly the use of immune checkpoint inhibitors, has yielded
impressive clinical benefits. Therefore, it is critical to accurately screen individuals for …

Current targeted therapy for metastatic colorectal cancer

T Ohishi, MK Kaneko, Y Yoshida, A Takashima… - International Journal of …, 2023‏ - mdpi.com
Colorectal cancer (CRC) is the third most common type of cancer and the second leading
cause of cancer deaths worldwide. Surgery or surgery plus radiotherapy and/or …